Drug treatment of multiple sclerosis. Clinical review was unsystematic

BMJ. 2001 Feb 3;322(7281):299.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Drug Costs
  • Humans
  • Interferon-beta / economics
  • Interferon-beta / therapeutic use
  • Multiple Sclerosis / drug therapy*
  • Review Literature as Topic
  • Treatment Outcome

Substances

  • Interferon-beta